Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment

Dipeptidyl peptidase-4 (DPP-4) inhibition is a new treatment for type-2 diabetes. DPP-4 inhibition increases levels of active GLP-1. GLP-1 enhances insulin secretion and diminishes glucagon secretion, in this manner reducing glucose concentrations in blood. A number of DPP-4 inhibitors are under cli...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of diabetes and metabolic disorders 2015-03, Vol.14, p.15-15
Hauptverfasser:	Sharma, Alok, Paliwal, Geetanjali, Upadhyay, Nisha, Tiwari, Archana
Format:	Artikel
Sprache:	eng
Schlagworte:	Care and treatment Dextrose Diabetes therapy Glucagon Glucose Health aspects Insulin Medical research Medicine, Botanic Medicine, Experimental Medicine, Herbal Physiological aspects Review Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!